Skip to content
Application 212304
- Type
- NDA
- Sponsor
- CORIUM, INC.
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | ADLARITY | DONEPEZIL HYDROCHLORIDE | SYSTEM;TRANSDERMAL | 5MG/24HR | No | No |
| 002 | ADLARITY | DONEPEZIL HYDROCHLORIDE | SYSTEM;TRANSDERMAL | 10MG/24HR | No | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 65038-055 | Adlarity | Donepezil Hydrochloride | Corium, Inc. | NDA | Current |
| 65038-055 | Adlarity | Donepezil Hydrochloride | Corium, Inc. | NDA | Current |
| 65038-056 | Adlarity | Donepezil Hydrochloride | Corium, Inc. | NDA | Current |
| 65038-056 | Adlarity | Donepezil Hydrochloride | Corium, Inc. | NDA | Current |
Documents#
Document, Submission type, Date table| Document | Submission type | Date |
|---|
| 72665 | ORIG | 2022-11-22 |
| 70521 | ORIG | 2022-03-15 |
| 70510 | ORIG | 2022-03-14 |